Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors
- PMID: 2777898
- DOI: 10.1002/jcp.1041410104
Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors
Abstract
This study reports on the effects of heparin, basic and acidic fibroblast growth factors (bFGF and aFGF, respectively), and transforming growth factor type-e (TGFe) on the growth of a human adrenocortical carcinoma cell line, SW-13. Heparin has previously been shown to inhibit growth in several cell types, including smooth muscle cells, certain fibroblasts, and epithelial cells, and to modulate the effects of fibroblast growth factors. Whereas bFGF and aFGF bind tightly to heparin and elute from a heparin-Sepharose column with 2 M NaCl and 1.6 M NaCl, respectively, TGFe binds to heparin with lower affinity and can be eluted from heparin-Sepharose column with 0.5 M NaCl. TGFe is a polypeptide unrelated to FGF, is present in neoplastic and nonneoplastic tissues, and stimulates the growth of certain epithelial cells and fibroblasts in soft agar and monolayer. Since the growth of SW-13 cells is stimulated by TGFe and by bFGF, we hypothesized that heparin would inhibit the growth of SW-13 cells by binding to these growth factors and that the effects of heparin could be overcome with the addition of either growth factor. Our experiments confirmed that heparin inhibits the growth of SW-13 cells. A dose-dependent growth inhibition was observed in both monolayer and soft agar. The inhibition in monolayer was partially reversed upon heparin withdrawal. The effects of heparin in both monolayer and soft agar were at least partially overcome by TGFe and by basic or acidic FGF. Overall protein synthesis does not appear to be affected by heparin as measured by [35S]methionine uptake. In contrast, epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) were unable to overcome heparin-induced inhibition both in monolayer and in soft agar. Heparin also inhibited [3H]thymidine incorporation in AKR-2B and partially inhibited AKR-2B cell stimulation by TGFe; however, it further potentiated the already potent stimulation by bFGF. We propose that heparin, TGFe, bFGF, and aFGF modulate the growth of SW-13 cells and possibly of other epithelial cells in complex ways and that heparin-like substances present in the extracellular matrix play an important role in the control of epithelial growth.
Similar articles
-
Purification and characterization of a novel transforming growth factor.Cancer Res. 1987 Sep 1;47(17):4552-9. Cancer Res. 1987. PMID: 2887280
-
Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive Shionogi carcinoma 115.J Cell Physiol. 1991 Aug;148(2):260-6. doi: 10.1002/jcp.1041480211. J Cell Physiol. 1991. PMID: 1715343
-
Comparison of the ability of basic and acidic fibroblast growth factor to stimulate the proliferation of an established keratinocyte cell line: modulation of their biological effects by heparin, transforming growth factor beta (TGF beta), and epidermal growth factor (EGF).J Cell Physiol. 1990 Feb;142(2):325-33. doi: 10.1002/jcp.1041420215. J Cell Physiol. 1990. PMID: 2303528
-
Potential role of HBGF (FGF) and TGF-beta on prostate growth.Adv Exp Med Biol. 1992;324:107-14. doi: 10.1007/978-1-4615-3398-6_11. Adv Exp Med Biol. 1992. PMID: 1492611 Review.
-
The fibroblast growth factor family: structural and biological properties.Prog Growth Factor Res. 1989;1(4):207-35. doi: 10.1016/0955-2235(89)90012-4. Prog Growth Factor Res. 1989. PMID: 2491263 Review.
Cited by
-
Endothelial cells transformed by SV40 T antigen cause Kaposi's sarcomalike tumors in nude mice.Am J Pathol. 1991 Oct;139(4):743-9. Am J Pathol. 1991. PMID: 1928299 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical